BSX - Boston Scientific Corporation
After hours:
Chart Events
Commodity Channel Index
Performance Outlook
- Short Term2W - 6W
- Mid Term6W - 9M
- Long Term9M+
| Previous Close | 51.54 |
| Open | 51.51 |
| Bid | 50.16 x 900 |
| Ask | 51.58 x 2900 |
| Day's Range | 50.93 - 51.92 |
| 52 Week Range | 34.98 - 54.17 |
| Volume | |
| Avg. Volume | 9,212,616 |
| Market Cap | 73.409B |
| Beta (5Y Monthly) | 0.80 |
| PE Ratio (TTM) | 86.54 |
| EPS (TTM) | 0.59 |
| Earnings Date | Jul 25, 2023 - Jul 31, 2023 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 58.22 |
Fair Value
Related Research
Simply Wall St.Can Boston Scientific Corporation (NYSE:BSX) Performance Keep Up Given Its Mixed Bag Of Fundamentals?
Boston Scientific's (NYSE:BSX) stock is up by 9.1% over the past three months. However, the company's financials look a...
ZacksWhy Is Boston Scientific (BSX) Down 0.9% Since Last Earnings Report?
Boston Scientific (BSX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
ZacksVeeva Systems (VEEV) Offerings Adopted by Minaris Regenerative
Veeva Systems' (VEEV) Vault Quality Suite applications are expected to aid the CDMO to modernize its operations and streamline its quality processes globally.
ZacksMedtronic (MDT) Q4 Earnings Beat Estimates, Margins Down
Strong growth in the Cardiovascular, Medical Surgical, and Neuroscience portfolios, and in Diabetes markets drove Medtronic (MDT) Q4 revenues.
BenzingaRegulatory Hurdles Force Boston Scientific to Opt for Minority Stake in M.I. Tech
Boston Scientific Corporation (NYSE: BSX) is terminating its $230 million plan to buy a majority stake in M.I. Tech, a publicly traded Korean manufacturer and distributor of medical devices for endoscopic and urologic procedures. The MedTech giant announced acquiring the Korean company in June last year at KRW 14,500 per share, representing KRW 291.2 billion or approximately $230 million. Also Read: Boston Scientific Clocks Strong Q1 Earnings As Elective Surgeries Recover, Boosts FY23 Outlook. “
- Zacks
Masimo's (MASI) Platform Expansion to Boost Patient Monitoring
Masimo's (MASI) latest expansion to its HEOS platform will likely revolutionize health and wellness tracking by allowing connected care as consumers become tetherless and smartphone-less.
ACCESSWIRE"I Truly Feel I’m Able To Be Who I Am at Boston Scientific"
NORTHAMPTON, MA / ACCESSWIRE / May 25, 2023 / Boston Scientific Lee (left) with her family When Jenny Lee was in middle school, her classmates aspired to be astronauts or the president of the United States. But Lee? "I wanted to be the ...
ZacksBoston Scientific (BSX) Gains From Acquisitions, New Launches
Boston Scientific (BSX) remains excited about 2023 performance and expects to continue to outpace its peers within the EMEA market.
ZacksAccuray (ARAY) Hits 52-Week High: What's Aiding the Stock?
Investors are optimistic about Accuray's (ARAY) solid product portfolio.
- Zacks
Veeva Systems' (VEEV) New Tie-Up to Improve Clinical Trials
Veeva Systems' (VEEV) latest collaboration is expected to advance the patient experience in clinical trials.
- Simply Wall St.
Boston Scientific Corporation's (NYSE:BSX) Intrinsic Value Is Potentially 20% Below Its Share Price
Key Insights Using the 2 Stage Free Cash Flow to Equity, Boston Scientific fair value estimate is US$41.38 Current...
ZacksAvantor's (AVTR) New Tie-Up to Improve Lab Inventory Management
Avantor's (AVTR) latest partnership is expected to significantly optimize labs' inventory management and the overall workflow.
- Zacks
3 Reasons to Add Merit Medical (MMSI) Stock to Your Portfolio
Investors continue to be optimistic about Merit Medical (MMSI) owing to its strong product portfolio.
- Zacks
3 Reasons to Hold Inspire Medical (INSP) Stock in Your Portfolio
Investors continue to be optimistic about Inspire Medical (INSP) on the back of its product innovations.
ZacksBD's (BDX) Latest Product Launch to Boost Research Outcome
BD's (BDX) latest cell sorting technology is expected to speed up the process of cell sorting and allow researchers to answer complex biological questions.
PR NewswireData at Heart Rhythm 2023 Highlight Key Boston Scientific Therapies
Boston Scientific Corporation (NYSE: BSX) today announced data supporting use of the company's key electrophysiology and cardiac rhythm management therapies, and the WATCHMAN FLX™ Left Atrial Appendage Closure (LAAC) Device. All data were presented at Heart Rhythm 2023, the annual meeting of the Heart Rhythm Society, held in New Orleans from May 19-21.
ZacksHCA Healthcare (HCA) Gains 29% in a Year: More Upside Left?
HCA Healthcare (HCA) is well-poised for growth on the back of higher revenues, a diversified treatment network and sound operating cash flows.
ZacksAre Medical Stocks Lagging Boston Scientific (BSX) This Year?
Here is how Boston Scientific (BSX) and Aravive (ARAV) have performed compared to their sector so far this year.
- PR Newswire
Boston Scientific to Participate in Bernstein's 39th Annual Strategic Decisions Conference
Boston Scientific Corporation (NYSE: BSX) will participate in Bernstein's 39th Annual Strategic Decisions Conference on Wednesday, May 31, 2023.
- Simply Wall St.
Boston Scientific Insiders Sold US$6.3m Of Shares Suggesting Hesitancy \
Many Boston Scientific Corporation ( NYSE:BSX ) insiders ditched their stock over the past year, which may be of...
Investor's Business DailyShockwave Eyes Buy Point After Quarterly Beat As Boston Sci Rumors Fizzle
Shockwave Medical easily beat first-quarter expectations, pushing SWAV stock closer to a breakout on Tuesday.
ZacksBoston Scientific (BSX) Just Overtook the 20-Day Moving Average
Good things could be on the horizon when a stock surpasses the 20-day simple moving average. How should investors react?
ACCESSWIREBoston Scientific: A Sense of Belonging and Purpose
NORTHAMPTON, MA / ACCESSWIRE / May 9, 2023 / Boston Scientific May is Asian American and Pacific Islander Heritage Month, and this year's theme is "Advancing Leaders Through Opportunity." Hear from two Boston Scientific employees about how their ...
ZacksZacks Industry Outlook Highlights Stryker, Boston Scientific, Zimmer Biomet and Insulet
Stryker, Boston Scientific, Zimmer Biomet and Insulet are part of the Zacks Industry Outlook article.
Zacks4 Medical Products Stocks to Capitalize on the Industry's Recovery
Despite the ongoing macro headwinds, recovering demand for medical procedures and cost-cutting initiatives should lend support to the Zacks Medical-Products industry. SYK, BSX, ZBH and PODD are well-poised to gain from the favorable factors.